A meta-analysis of randomized trials for effects of atorvastatin on renal function in chronic kidney disease

International Journal of Cardiology

Volumn 152, Issue 2, 2011, Pages 242-244

  Takagi, Hisato ^a   Umemoto, Takuya ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Atorvastatin; Chronic kidney disease; Meta analysis; Randomized controlled trial; Renal function

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; PLACEBO; PROBUCOL;

CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART INFARCTION; HUMAN; KIDNEY FUNCTION; LETTER; MAJOR CLINICAL STUDY; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; TREATMENT DURATION;

EID: 80053569944     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.06.107     Document Type: Article

References (18)

1. S.D. Navaneethan, F. Pansini, and V. Perkovic HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Cochrane Database Syst Rev 2 2009 CD007784
2. R.G. Fassett, I.K. Robertson, M.J. Ball, D.P. Geraghty, and J.S. Coombes Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial Atherosclerosis 213 2010 218 224
3. J. Shepherd, J.J. Kastelein, and V. Bittner Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study Clin J Am Soc Nephrol 2 2007 1131 1139
4. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470 (Pubitemid 29135798)
5. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
6. Higgins JP, Deeks JJ, editors. Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
7. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
8. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634 (Pubitemid 27387172)
9. M.J. Koren, M.H. Davidson, D.J. Wilson, R.S. Fayyad, A. Zuckerman, and D.P. Reed ALLIANCE Investigators. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD Am J Kidney Dis 53 2009 741 750
10. S. Bianchi, R. Bigazzi, A. Caiazza, and V.M. Campese A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease Am J Kidney Dis 41 2003 565 570 (Pubitemid 36278373)
11. H.M. Colhoun, D.J. Betteridge, and P.N. Durrington Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS) Am J Kidney Dis 54 2009 810 819
12. M. Goicoechea, S.G. de Vinuesa, and V. Lahera Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease J Am Soc Nephrol 17 12 Suppl. 3 2006 S231 S235
13. M.K. Rutter, H.R. Prais, and V. Charlton-Menys Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1) Diabet Med 28 2011 100 108
14. J. Sorof, C. Berne, A. Siewert-Delle, L. Jørgensen, and P. Sager URANUS study investigators. Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients Diabetes Res Clin Pract 72 2006 81 87
15. G. Yasuda, D. Ando, N. Hirawa, and S. Umemura Effects of atorvastatin versus probucol on low-density lipoprotein subtype distribution and renal function in hyperlipidemic patients with nondiabetic nephropathy Ren Fail 32 2010 680 686
16. G.F. Strippoli, S.D. Navaneethan, and D.W. Johnson Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials BMJ 336 2008 645 651 (Pubitemid 351481234)
17. H. Holdaas, C. Wanner, C. Abletshauser, C. Gimpelewicz, and J. Isaacsohn The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials Int J Cardiol 117 2007 64 74 (Pubitemid 46402940)
18. L.G. Shewan, and A.J. Coats Ethical authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2